LAMIVUDINE vs RESCRIPTOR

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 14, 2026·How we rate

Possible drug interaction. LAMIVUDINE and RESCRIPTOR are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	LAMIVUDINE	RESCRIPTOR
Rating	66/100	New
Pharmacy pays	$0.44 /mL	—
Type	RX	RX
Active ingredient	LAMIVUDINE	DELAVIRDINE MESYLATE
Manufacturer	Apotex	Viiv Hlthcare
Dosage forms	Tablet	Tablet
Drug class	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor	—
Boxed warning	Boxed warning	None
Treats	Acquired Immunodeficiency Syndrome	Acquired Immunodeficiency Syndrome

lamivudine rescriptor

Rating

66/100

New

Pharmacy pays

$0.44 /mL

—

Type

Active ingredient

LAMIVUDINE

DELAVIRDINE MESYLATE

Manufacturer

Apotex

Viiv Hlthcare

Dosage forms

Tablet

Drug class

Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor

—

Boxed warning

None

Treats

Acquired Immunodeficiency Syndrome

Frequently asked questions

What is the difference between Lamivudine and Rescriptor?

Lamivudine contains Lamivudine, while Rescriptor contains Delavirdine Mesylate — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.